Israeli company Syqe Medical has created an inhaler that vaporises medicinal marijuana for patients to ingest, without causing inhibiting psychoactive effects. The Syqe Inhaler is a 3D-printed tool that administers metered doses of marijuana.
Marijuana laws continue to be relaxed worldwide, yet in terms of its medical application the drug still struggles to gain mainstream acceptance within the medical profession, as it does not fit the standardised prescription model and can inhibit the functionality of patients.
The Syqe Inhaler addresses this by administering 100 microgram capsules containing the optimum amount of THC (the chemical that gets you high) and CBD (the chemical that is known for its anti-inflammatory and pain relief qualities). It is therefore able to create a precise balance between symptom relief and psychoactivity.
Doctors will be able to monitor their patients’ intake of marijuana and administer further dosage via an app that connects to the Syqe Inhaler’s inbuilt Wi-Fi.
The inhaler is currently undergoing clinical trials; initial tests suggest it is more effective than other ingestion methods, such as inhalers.
Image credits:Park Ranger / Flickr
If special licenses evolve into legislation, the Syqe Inhaler could pave the way for a new form of medicinal marijuana as commonly prescribed as current pain killers.
Medical benefits of marijuana include its ability to control muscle spasms, pain relief, and preventing nausea and appetite loss during chemotherapy and AIDS treatment. However, its potential to cause or worsen mental health issues is where it draws significant criticism, especially in relation to long term exposure.
The ability of scientists to isolate the chemicals that make a drug beneficial could see more drugs, previously excluded from western medicine, on prescription.